Trinity Biotech (TRIB) has obtained an additional $4M in debt financing from its primary lender, Perceptive Advisors. The additional liquidity ...

1 Day TRIB 0.00% DJIA -0.37% Russell 2K -0.10% Health Care/Life Sciences 0.69% ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Abbott had claimed that the shape of Sinocare’s iCan i3 wearable CGM was too similar to its own FreeStyle Libre sensor—in this case, the small, white disc placed on the upper arm. Sinocare ...

As climate change looms over us all, many industries are turning to biotechnology for solutions to make all aspects of our lives more sustainable for the environment. Biotechnology is uniquely ...

(MENAFN- GlobeNewsWire - Nasdaq) Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...

Trinity Biotech ( (TRIB)) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous glucose monitoring (CGM) system, following its latest pre ...

(RTTNews) - Trinity Biotech plc (TRIB), a biotechnology company ... for its next-generation continuous glucose monitoring or CGM system. The findings show approximately 35 percent improvement ...